FDA Alert: Fentanyl Transdermal System: Recall - Potential for Active Ingredient to Release Faster Than Specified
Links shared publicly online about this topic.
- 780total visits
FDA Alert: Fentanyl Transdermal System: Recall - Potential for Active Ingredient to Release Faster Than Specified
FDA Alert: Fentanyl Transdermal System: Recall - Potential for Active Ingredient to Release Faster Than Specified
View full resource at drugs.com
Tags: Cancer Pain Medication, FDA, Duragesic, Actiq
Most Recently Shared on October 23, 2010 at 5:51 pm By:
FDA Alert - Recall: Fentanyl Transdermal System - Potential for Active Ingredient to Release Faster Than Specified - http://bit.ly/9y1Vnk
Advertisement
